Bortesam Injections – Bortezomib Injection in India

Bortesam Injections contain bortezomib, a proteasome inhibitor used as part of specialist-directed treatment for certain blood cancers. Bortesam is intended for use under the supervision of a qualified oncologist or hematologist, with treatment decisions based on the patient's diagnosis, overall health, laboratory results and prescribed treatment protocol.

For patients, hospitals and healthcare professionals searching online for Bortesam Injections in India, understanding the medicine, available strengths and appropriate medical supervision is important before considering purchase or treatment.

Bortesam Injection Product Description

Bortesam contains bortezomib, which works by inhibiting proteasomes, cellular structures involved in the breakdown of proteins. Blocking this process can interfere with the growth and survival of certain abnormal blood cells. Bortezomib is clinically used in the management of multiple myeloma and mantle cell lymphoma in appropriate patients.

Bortesam Injection is supplied as a vial intended to be prepared and administered by trained healthcare professionals. Depending on the prescribed formulation and clinical protocol, bortezomib may be administered by subcutaneous or intravenous injection. The route, concentration and dose must be determined by the treating specialist because preparation requirements differ between administration routes.

Bortezomib dosing is individualized rather than being a standard dose for every patient. The prescribing information states a commonly used starting dose of 1.3 mg/m², but the actual treatment schedule and dose modifications depend on the patient's condition, treatment combination, tolerance and clinical assessment.

Bortesam Injection Strengths

Bortesam may be available in different vial strengths depending on the marketed presentation and applicable approvals.

Common bortezomib injection strengths include:

Bortesam 1 mg Injection

Bortesam 3.5 mg Injection

The 3.5 mg presentation is supplied as a single-dose vial in approved bortezomib injection labeling.

Patients should not select a strength independently. The required vial strength and quantity are determined according to the prescribed dose and the patient's body-surface area and treatment plan.

Important Safety Information

Bortesam is a prescription medicine and should only be used according to a specialist's instructions. Bortezomib treatment can cause adverse effects including peripheral neuropathy, low blood-cell counts, nausea, diarrhea, constipation, vomiting, fatigue and other reactions. Monitoring may be required during treatment.

It should not be administered intrathecally. Patients should inform their healthcare provider about existing medical conditions, current medicines and any previous reactions to bortezomib or its ingredients.

FAQs About Bortesam Injections

1. What is Bortesam Injection used for?

Bortesam contains bortezomib and is used under specialist supervision for appropriate patients with conditions such as multiple myeloma and mantle cell lymphoma.

2. What are the strengths of Bortesam Injection?

Bortesam may be available in 1 mg and 3.5 mg vial presentations, subject to product availability and applicable approvals.

3. Can I buy Bortesam Injection online in India?

Bortesam is a prescription medicine. Patients should purchase it only through legitimate, licensed pharmaceutical channels and use it only when prescribed by an authorized healthcare professional.

4. Who should administer Bortesam?

Bortesam should be prepared and administered by appropriately trained healthcare professionals according to the prescribed route and treatment protocol.

5. Can I decide the Bortesam dose myself?

No. Bortezomib dosing is individualized. The treating oncologist or hematologist should determine the appropriate dose and schedule.

6. What should I do if I experience side effects?

Contact your treating healthcare professional promptly. Symptoms such as significant weakness, breathing difficulties, severe neurological symptoms or other serious reactions require immediate medical evaluation.

About Cordium Pharmaceuticals Pvt Ltd

Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical company engaged in the supply and distribution of pharmaceutical products. For information regarding Bortesam availability, product specifications, packaging and supply requirements in India, healthcare institutions, pharmaceutical businesses and eligible buyers can contact Cordium Pharmaceuticals Pvt Ltd directly.

Product availability may vary, and all purchases should comply with applicable Indian prescription, pharmaceutical distribution and regulatory requirements.